Related Experiment Video

Updated: Jun 6, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Bioanalysis of meningococcal vaccines

Neil Ravenscroft1, Jun X Wheeler, Christopher Jones

  • 1Bioanalytical and Vaccine Research, Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa. Neil.Ravenscroft@uct.ac.za

Bioanalysis
|November 19, 2010
PubMed

Insights

Meningococcal meningitis vaccines target specific serogroups. This review explores physicochemical methods for characterizing polysaccharide and outer-membrane protein vaccines, addressing challenges in meningococcal vaccine development.

Area of Science:

  • Microbiology
  • Vaccinology
  • Biochemistry

Background:

  • Meningococcal meningitis, caused by Neisseria meningitidis, presents a significant public health threat due to its rapid progression.
  • Five serogroups (A, B, C, W, Y) are responsible for most disease cases, necessitating targeted vaccine strategies.
  • Current vaccines offer protection against four serogroups via polysaccharide or glycoconjugate approaches, while group B requires outer-membrane protein (OMP) vaccines.

Purpose of the Study:

  • To review physicochemical approaches for the characterization and quality control of meningococcal vaccines.
  • To highlight the distinct challenges and design considerations for vaccines targeting different meningococcal serogroups.
  • To discuss the current status and future directions of OMP-based vaccines for serogroup B.

Main Methods:

  • Review of literature on physicochemical characterization techniques relevant to polysaccharide and protein-based vaccines.
  • Analysis of vaccine design principles for different serogroups.
  • Discussion of challenges in developing and implementing outer-membrane vesicle (OMV) vaccines.

Main Results:

  • Glycoconjugate vaccines are established for four serogroups, utilizing anticarbohydrate immune responses.
  • Outer-membrane protein vaccines, particularly for serogroup B, face significant development and characterization challenges.
  • Physicochemical methods are crucial for ensuring the quality and efficacy of both vaccine types.

Conclusions:

  • Effective meningococcal meningitis control requires serogroup-specific vaccine strategies.
  • Advancements in physicochemical characterization are vital for the successful development and quality control of novel meningococcal vaccines, especially OMP-based formulations.
  • Understanding the differences in vaccine design for various serogroups is key to combating the disease globally.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Visualisation and Quantification of Intracellular Interactions of Neisseria meningitidis and Human α-actinin by Confocal Imaging12:58

Visualisation and Quantification of Intracellular Interactions of Neisseria meningitidis and Human α-actinin by Confocal Imaging

Published on: October 24, 2010

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...